natgillin/translations-raw huggingface dataset:
Do not use the residual scale to measure your dose of insulin • You will hear a click for every single unit dialled.
Merila preostanka ne uporabljajte za merjenje odmerka insulina. • Za vsako posamezno nastavljeno enoto boste slišali klik.
You cannot set a dose larger than the number of units left in the cartridge.
Odmerka, ki bi bil večji od števila preostalih enot v vložku, ne morete nastaviti.
Use the injection technique advised by your doctor • Deliver the dose by pressing the push-button fully down (picture 3).
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik. • Odmerek injicirajte tako, da potisni gumb pritisnete do konca (slika 3).
You will hear clicks as the dose selector returns to zero • After the injection, the needle must remain under the skin for at least 6 seconds to ensure that the full dose has been delivered • Make sure not to block the dose selector while injecting, as the dose selector must be allowed to return to zero when you press the push-button • Remove the needle after each injection.
Slišali boste klike, ko se bo izbirnik odmerka vračal na ničlo. • Po injiciranju mora igla ostati pod kožo vsaj 6 sekund, da je zagotovljeno injiciranje celotnega odmerka. • Pazite, da izbirnika odmerka med injiciranjem ne boste ovirali, kajti pustiti mu je treba, da se vrne na ničlo, medtem ko pritiskate potisni gumb. • Iglo morate po vsakem injiciranju odstraniti.
242 3
243 3
Remove the needle after each injection and store InnoLet without the needle attached.
Po vsakem injiciranju morate iglo odstraniti in zavreči, NovoLet pa shraniti brez nameščene igle.
Dispose of your used Actraphane 30 InnoLet carefully without the needle attached.
Odrabljeni peresnik Actraphane 30 InnoLet pazljivo zavrzite; pazite, da boste pred tem z njega odstranili iglo.
Your Actraphane 30 InnoLet is designed to work accurately and safely.
Vaš Actraphane 30 InnoLet je izdelan za natančno in varno delovanje.
Do not refill Actraphane 30 InnoLet.
Peresnika Actraphane 30 InnoLet se ne sme znova polniti.
You can clean your Actraphane 30 InnoLet by wiping it with a medicinal swab.
Zunanjost peresnika Actraphane 30 InnoLet lahko očistite tako, da ga obrišete z medicinskim zložencem.
INFORMATION FOR THE USER
244 NAVODILO ZA UPORABO
Do not pass it on to others.
Morda ga boste želeli ponovno prebrati. – Če imate dodatna vprašanja, se posvetujte z zdravnikom, medicinsko sestro ali s farmacevtom. – Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or your pharmacist.
Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim. – Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, medicinsko sestro ali farmacevta.
How to store Actraphane 7.
Shranjevanje zdravila Actraphane 30 FlexPen 7.
How to use your FlexPen
Kako uporabljati FlexPen
244 Your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; beta- sympathomimetics; growth hormone; danazol; octreotide or lanreotide.
245 Vaša potreba po insulinu se lahko spremeni, če uporabljate tudi: peroralna antidiabetična zdravila, zaviralce monoaminooksidaze (MAOI), zaviralce receptorjev beta, zaviralce ACE, acetilsalicilno kislino, anabolne steroide, sulfonamide, oralne kontraceptive, tiazide, glukokortikoide, zdravljenje s ščitničnimi hormoni, beta- simpatikomimetike, rastni hormon, danazol, oktreotid in lanreotid.
Talk about your insulin needs with your doctor and nurse.
O svoji potrebi po insulinu se posvetujte z zdravnikom in medicinsko sestro.
► In insulin infusion pumps ► If FlexPen is dropped, damaged or crushed there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or been frozen (see 6 How to store Actraphane) ► If it’ s not uniformly white and cloudy when it’ s resuspended.
Ne uporabljajte zdravila Actraphane, v insulinskih infuzijskih črpalkah; ► če vložek FlexPen pade, se poškoduje ali z njim kam udarite, ker obstaja nevarnost in ► puščanje insulina; če ni bilo shranjeno pravilno ali je zamrznilo (glejte poglavje 6.
245 unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Če se pojavi kateri od teh znakov, zaužijte tablete glukoze ali prigrizek, ki vsebuje veliko sladkorja (bonbone, piškote, sadni sok), in nato počivajte.
Don’ t take any insulin if you feel a hypo coming on.
246 Če čutite, da se pojavlja hipa, si ne dajajte insulina.
Then seek medical advice straight away.
Če se pojavi kateri od teh znakov, si izmerite sladkor v krvi, določite ketone v urinu, če imate to možnost, potem pa takoj poiščite zdravniški nasvet.
246 Side effects reported uncommonly (in less than 1 patient in 100)
Občasno opisani neželeni učinki
If you notice your skin pitting or thickening at the injection site, tell your doctor or nurse because these reactions can become more severe, or they may change the absorption of your insulin if you inject in such a site.
Če na mestu injiciranja opazite ugreznjenost ali izbočenost kože, morate to povedati zdravniku ali medicinski sestri.
The FlexPen that is not being used is to be stored in a refrigerator (2°C - 8°C).
FlexPen, ki ni v uporabi, shranjujte v hladilniku (med 2 °C in 8 °C).
The FlexPen that is being used, about to be used or carried as a spare is not to be kept in a refrigerator.
FlexPen, ki je v uporabi, ki ga boste pravkar uporabili ali ki ga nosite s seboj za rezervo, ne shranjujte v hladilniku!
After removing theFlexPen from the refrigerator it is recommended to let it reach room temperature before resuspending the insulin as instructed for the first time use.
Potem, ko Actraphane FlexPen vzamete iz hladilnika, ga je priporočljivo pustiti, da doseže sobno temperaturo, preden insulin resuspendirate po navodilu za prvo uporabo.
Always keep the pen cap on your FlexPen when you’ re not using it in order to protect it from light.
Kadar injekcijskega peresnika FlexPen ne uporabljate, naj bo vedno pokrit s pokrovčkom, da bo zaščiten pred svetlobo.
247 7.
248 7.
What Actraphane looks like and contents of the pack The suspension for injection comes as a cloudy, white, aqueous suspension in packs.
Izgled zdravila Actraphane in vsebina pakiranja Suspenzija za injiciranje je motna, bela, vodna suspenzija, opremljena v pakiranjih z 1, 5 ali 10 napolnjenih injekcijskih peresnikov po 3 ml vialami (na trgu lahko ni vseh navedenih pakiranj).
Not all packs may be marketed.
Imetnik dovoljenja za promet Novo Nordisk A/ S Novo Allé, DK- 2880 Bagsværd, Danska
Marketing Authorisation Holder Novo Nordisk A/ S Novo Allé, DK-2880 Bagsværd, Denmark
Izdelovalec Izdelovalca je mogoče ugotoviti po serijski številki, natisnjeni na etiketi škatle in na nalepki:
Manufacturer The manufacturer can be identified by the batch number printed on the slip of the carton and on the label: – If the second and third characters are W5, S6, P5, K7, or ZF Novo Nordisk A/ S, Novo Allé, DK-2880 Bagsværd, Denmark is the manufacturer
– Če sta drugi in tretji znak W5, S6, P5, K7 ali ZF, je izdelovalec Novo Nordisk A/ S, Novo Allé, DK- 2880 Bagsværd, Danska.
– If the second and third characters are H7 or T6 Novo Nordisk Production SAS, 45 Avenue d’ Orléans, F-28002 Chartres, France is the manufacturer.
– Če sta drugi in tretji znak H7 ali T6, je izdelovalec Novo Nordisk Production SAS, 45 Avenue d’ Orléans, F- 28002 Chartres, Francija.
Now turn over for information on how to use your FlexPen.
Zdaj navodilo za uporabo obrnite, da boste prebrali informacije o tem, kako uporabljati FlexPen.
248 Introduction
249 Uvod
Please read the following instructions carefully before using your Actraphane FlexPen.
Preden uporabite Actraphane FlexPen, natančno preberite ta navodila
Your FlexPen is a unique dial-a-dose insulin pen.
Vaš FlexPen je edinstven insulinski peresnik z gumbom za nastavitev odmerka.
FlexPen is designed and tested to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
FlexPen je namenjen in preizkušen za uporabo z iglami NovoFine ali NovoTwist za enkratno uporabo, dolžine do 8 mm.
As a precautionary measure, always carry a spare insulin delivery device in case your FlexPen is lost or damaged.
Iz previdnosti vedno nosite s seboj rezervni peresnik za injiciranje insulina, v primeru, da FlexPen izgubite ali se poškoduje.
The colour of the pen in the illustrations differs from your FlexPen.
Barva peresnika na ilustraciji se razlikuje od barve vašega peresnika FlexPen.
Actraphane 30 FlexPen Pen cap
Actraphane 30 FlexPen pokrovček peresnika
12 units Glass
gumijasta 12 enot steklena
Cartridge
vložek
Residual
merilo
Pointer
kazalnik izbirnik
Push-
membrana
membrane
kroglica
scale
preostanka
selector
odmerka
Needle (example)
Igla (primer)
Big outer
veliki zunanji
Inner
notranji
Needle
igla
Protective
zaščitna nalepka
needle cap needle cap
pokrovček igle
tab
pokrovček igle
Your FlexPen is designed to work accurately and safely.
Vaš FlexPen je izdelan za natančno in varno delovanje.
If it is dropped or crushed, there is a risk of damage and leakage of insulin.
Če vam pade ali se zdrobi, obstaja nevarnost okvare in puščanja insulina.
You can clean the exterior of your FlexPen by wiping it with a medicinal swab.
Zunanjost peresnika FlexPen lahko očistite tako, da ga obrišete z medicinskim zložencem.
Do not refill your FlexPen.
Peresnika FlexPen ne smete znova polniti.
Preparing your Actraphane FlexPen
250 Priprava peresnika Actraphane FlexPen
Check the label to make sure that your FlexPen contains the correct type of insulin.
Preverite nalepko in se tako prepričajte, da vaš FlexPen vsebuje pravo vrsto insulina.
249 A Let the insulin reach room temperature before you use it.
A Preden insulin uporabite, ga pustite, da doseže sobno temperaturo.
B Move the pen up and down twenty times between position 1 and 2 as shown, so the glass ball moves from one end of the cartridge to the other.
B Potem peresnik dvajsetkrat obrnite gor in dol med položajema 1 in 2, kot je prikazano, tako da se steklena kroglica premika z enega konca vložka na drugega.
Repeat until the liquid appears uniformly white and cloudy.
Ponavljajte postopek vrtenja in obračanja peresnika, dokler ni tekočina enakomerno bela in motna.
For every following injection move the pen up and down between position 1 and 2 at least ten times until the liquid appears uniformly white and cloudy.
Za vsako naslednje injiciranje obrnite peresnik z vložkom vsaj desetkrat gor in dol med položajema 1 in 2, dokler ni tekočina enakomerno bela in motna.
• Always check there are at least 12 units of insulin left in the cartridge to allow resuspension.
• Vedno preverite, ali je v vložku vsaj še 12 enot insulina, tako da je resuspendiranje mogoče.
If there are less than 12 units left, use a new FlexPen.
Če je preostalo manj kot 12 enot, uporabite nov FlexPen.
Disinfect the rubber membrane with a medicinal swab.
Dezinficirajte gumijasto membrano z medicinskim zložencem.
C Remove the protective tab from a new disposable needle.
C Odstranite zaščitno nalepko z nove igle za enkratno uporabo.
Screw the needle straight and tightly onto your FlexPen.
Iglo naravnost in trdno privijte na FlexPen.
C
251 C
D Pull off the big outer needle cap and keep it for later.
D Snemite veliki zunanji pokrovček in ga shranite za pozneje.
E Pull off the inner needle cap and dispose of it.
E Snemite notranji pokrovček igle in ga zavrzite.
• Always use a new needle for each injection to prevent contamination.
• Za vsako injiciranje uporabite novo iglo, da boste preprečili kontaminacijo.
• To reduce the risk of unexpected needle sticks, never put the inner needle cap back on when you have removed it from the needle.
• Da boste zmanjšali tveganje za neželene vbode z iglo, nanjo nikdar znova ne nameščajte notranjega pokrovčka igle, ki ste ga že sneli.
2 units- selected
izbrani 2 enoti
G Hold your FlexPen with the needle pointing upwards and tap the cartridge gently with your finger a few times to make any air bubbles collect at the top of the cartridge.
G Držite FlexPen tako, da je igla obrnjena navzgor, in s prstom nekajkrat rahlo potrkajte po vložku, da se bodo morebitni zračni mehurčki zbrali na vrhu vložka.
G
252 G
251 H Keeping the needle upwards, press the push-button all the way in.
H Z iglo obrnjeno navzgor pritisnite potisni gumb do konca.
If not, change the needle and repeat the procedure no more than six times.
Če se ne, zamenjajte iglo in ponovite postopek, vendar ne več kot šestkrat.
I Turn the dose selector to select the number of units you need to inject.
I Zavrtite izbirnik odmerka, da boste izbrali število enot, ki jih morate injicirati.
I
253 I
• Do not use the residual scale to measure your dose of insulin.
• Merila preostanka ne uporabljajte za merjenje odmerka insulina.
252 J Inject the dose by pressing the push-button all the way in until 0 lines up with the pointer.
J Odmerek injicirajte tako, da potisni gumb pritisnete do konca in se 0 uravna s kazalnikom.
K Keep the push-button fully depressed after the injection until the needle has been withdrawn from the skin.
K Po injiciranju držite potisni gumb povsem pritisnjen, dokler igle ne potegnete iz kože.
The needle must remain under the skin for at least six seconds.
Igla mora ostati pod kožo vsaj šest sekund.
This will ensure that the full dose has been injected.
Tako zagotovite injiciranje celotnega odmerka.
L Lead the needle into the big outer needle cap without touching the big outer needle cap.
L Konico igle vstavite v veliki zunanji pokrovček igle, ne da bi se ga dotaknili.
Dispose of it carefully and put the pen cap back on.
Pazljivo jo zavrzite in na peresnik znova namestite njegov pokrovček.
L
254 L
• Always remove the needle after each injection and store your FlexPen without the needle attached.
• Po vsakem injiciranju morate iglo odstraniti in zavreči, FlexPen pa shraniti brez nameščene igle.
Otherwise, the liquid may leak out which can cause inaccurate dosing.
V nasprotnem primeru lahko tekočina izteka in to lahko povzroči netočno odmerjanje.
• Caregivers should be most careful when handling used needles to avoid needle sticks.
• Osebe, ki skrbijo za bolnika, morajo biti pri ravnanju z uporabljenimi iglami nadvse pazljive, da se z njimi ne zbodejo.
• Dispose of the used FlexPen carefully without the needle attached.
• Odrabljeni peresnik FlexPen pazljivo zavrzite; pazite, da boste pred tem z njega odstranili iglo.
• Do not share your FlexPen with anyone else.
• Peresnika FlexPen si ne delite z drugimi.
253
255
Actrapid is a solution for injection.
Zdravilo Actrapid je raztopina za injiciranje.
It is available in a vial, a cartridge (PenFill) or in a prefilled pen (NovoLet, FlexPen or InnoLet).
Na voljo je v viali, vložkih (PenFill) ali v napolnjenih injekcijskih peresnikih (NovoLet, FlexPen ali InnoLet).
Actrapid contains the active substance insulin human (rDNA).
Zdravilo Actrapid vsebuje zdravilno učinkovino humani insulin (rDNA).
Actrapid is used in patients who have diabetes.
Zdravilo Actrapid se uporablja za zdravljenje sladkorne bolezni.
Actrapid is administered subcutaneously (under the skin) by injection, usually into the abdominal wall (tummy).
Actrapid se daje subkutano (pod kožo), navadno z injiciranjem v trebušno steno.
The thigh, the deltoid region (shoulder) or the gluteal region (buttocks) may also be used.
Injicira se lahko tudi v stegno, deltoidni predel (rame) ali glutealni predel (zadnjica).
The patient's blood glucose (sugar) should be tested regularly to find the lowest effective dose.
Za določitev najnižjega učinkovitega odmerka je potrebno redno spremljati raven glukoze (sladkorja) v krvi bolnika.
The usual dose is between 0.3 and 1.0 international units (IU) per kilogram body weight per day.
Običajni odmerek znaša med 0, 3 in 1, 0 mednarodnih enot (i. e.) na kilogram telesne mase na dan.
Actrapid is a fast-acting insulin and may be used with long-acting insulins.
Actrapid je hitrodelujoči insulin in se lahko uporablja v kombinaciji z dolgodelujočimi insulini.
Diabetes is a disease in which the body does not produce enough insulin to control the blood glucose.
Sladkorna bolezen je bolezen, pri kateri telo ne tvori dovolj insulina za uravnavanje glukoze v krvi.
Actrapid is a replacement insulin that is identical to the insulin made by the pancreas.
Actrapid je nadomestni insulin, ki je enak insulinu, ki ga proizvaja trebušna slinavka.
The active substance in Actrapid, insulin human (rDNA), is produced by a method known as ‘ recombinant technology’: the insulin is made by a yeast that has received a gene (DNA), which makes it able to produce insulin.
Zdravilna učinkovina zdravila Actrapid je humani insulin (rDNA), izdelan z metodo, imenovano „ rekombinantna tehnologija “: insulin izdela kvasovka, ki je prejela gen (DNA), s pomočjo katerega lahko tvori insulin.
The replacement insulin acts in same way as naturally produced insulin and helps glucose enter cells from the blood.
Nadomestni insulin deluje na enak način kot naravno proizvedeni insulin in omogoča, da lahko glukoza vstopi iz krvi v celico.
By controlling the blood glucose, the symptoms and complications of diabetes are reduced.
Z nadzorovanjem glukoze v krvi se zmanjšajo simptomi in zapleti, povezani s sladkorno boleznijo.
Actrapid has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and type 2 diabetes, when the body is unable to use insulin effectively (one study involving 182 patients).
Actrapid se preučevali pri bolnikih s sladkorno boleznijo tipa 1, pri kateri trebušna slinavka ne more tvoriti insulina (dve študiji, ki sta vključevali 1. 954 bolnikov), in pri bolnikih s sladkorno boleznijo tipa 2, pri kateri telo ne more učinkovito izrabiti insulina (ena študija, ki je vključevala 182 bolnikov).
The studies compared Actrapid to a human insulin analogue (insulin aspart) over six months by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
V študijah so v obdobju šestih mesecev primerjali zdravilo Actrapid z analogom humanega insulina
(44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Actrapid shown during the studies?
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged (insulin aspart) tako, da so merili raven snovi v krvi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako učinkovito je glukoza v krvi nadzorovana.
HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
Ravni HbA1c so v šestmesečnem zdravljenju z zdravilom Actrapid ostale razmeroma stalne.
As with all insulins, Actrapid may cause hypoglycaemia (low blood glucose).
Kot vsi insulini lahko tudi zdravilo Actrapid povzroči hipoglikemijo (nizko raven glukoze v krvi).
For the full description of all side effects reported with Actrapid, see the Package Leaflet.
Za celoten opis vseh neželenih učinkov, o katerih so poročali pri uporabi zdravila Actrapid, glejte Navodilo za uporabo.
Actrapid should not be used in people who may be hypersensitive to insulin human (rDNA) or any of the other ingredients.
Zdravila Actrapid se ne sme uporabljati pri ljudeh, ki utegnejo biti preobčutljivi za humani insulin (rDNA) ali katerokoli drugo sestavino zdravila.
Actrapid doses might also need to be adjusted when given with a number of other medicines which may have an effect on blood glucose.
Odmerke zdravila Actrapid bo morda potrebno prilagoditi, če se zdravilo jemlje istočasno z drugimi zdravili, ki lahko vplivajo na koncentracijo glukoze v krvi.
The full list is available in the Package Leaflet.
Celoten seznam je na voljo v Navodilu za uporabo.
The Committee for Medicinal products for Human Use (CHMP) decided that Actrapid’ s benefits are greater than its risks for the treatment of diabetes mellitus.
Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Actrapid pri zdravljenju sladkorne bolezni večje od z njim povezanih tveganj.
The Committee recommended that Actrapid be given marketing authorisation.
Zato je priporočil, da se za zdravilo Actrapid odobri dovoljenje za promet z zdravilom.
Other information about Actrapid:
Druge informacije o zdravilu Actrapid:
The European Commission granted a marketing authorisation valid throughout the European Union for Actrapid to Novo Nordisk A/ S on 7 October 2002.
Evropska komisija je dovoljenje za promet z zdravilom Actrapid, veljavno po vsej Evropski uniji, odobrila družbi Novo Nordisk A/ S dne 7. oktobra 2002.
The marketing authorisation was renewed on 7 October 2007.
Dovoljenje za promet z zdravilom je bilo podaljšano 7. oktobra 2007.
The full EPAR for Actrapid can be found here.
Celotno Evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Actrapid je na voljo tukaj.
This summary was last updated in 10-2007.
Povzetek je bil nazadnje posodobljen 10- 2007.
Subcutaneous and intravenous use
za subkutano ali intravensko uporabo
10ml (1.4 mg/ ml) 1 vial
1 viala
10 ml (1.4 mg/ ml) 5 vials
5 vial
10 ml (3.5 mg/ ml) 1 vial
1 viala
10 ml (3.5 mg/ ml) 5 vials
5 vial
3 ml (3.5 mg/ ml) 1 cartridge
1 injekcijski vložek
3 ml (3.5 mg/ ml) 5 cartridges
5 injekcijskih vložkov
3 ml (3.5 mg/ ml) 10 cartridges
10 injekcijskih vložkov
Cartridge (glass) in pre- filled pen
injekcijski vložek (steklo) v napolnjenem peresniku
3 ml (3.5 mg/ ml) 5 pre-filled pens
5 napolnjenih peresnikov
3 ml (3.5 mg/ ml) 10 pre-filled pens
10 napolnjenih peresnikov
3 ml (3.5 mg/ ml) 1 pre-filled pen
1 napolnjen peresnik
1/ 2 EU number
1/ 2 EU številka
Cartridge (glass) in pre- 3 ml (3.5 mg/ ml) filled pen
injekcijski vložek (steklo) v napolnjenem peresniku
Actrapid 40 IU/ ml solution for injection in a vial.
Actrapid 40 i. e. / ml raztopina za injiciranje v viali
1 vial contains 10 ml equivalent to 400 IU.
1 viala vsebuje 10 ml, kar ustreza 400 i. e.
Actrapid is a fast-acting insulin and may be used in combination with long-acting insulin products.
Actrapid je hitrodelujoč insulin in se lahko uporablja v kombinaciji z dolgodelujočimi insulinskimi zdravili.
Adjustment of dosage may also be necessary if patients change physical activity or their usual diet.
Prilagoditev odmerjanja utegne biti potrebna tudi v primeru, da bolniki spremenijo svojo telesno dejavnost ali običajno prehrano.
2 Administration For subcutaneous or intravenous use.
2 Način uporabe Za subkutano ali intravensko uporabo.
Actrapid may also be administered intravenously, which should only be carried out by health care professionals.
Actrapid je mogoče aplicirati tudi intravensko, vendar ga sme tako uporabiti samo zdravstveno osebje.
Actrapid is administered subcutaneously in the abdominal wall.
Actrapid se aplicira subkutano v trebušno steno.
The thigh, the gluteal region or the deltoid region may also be used.
Uporabiti je mogoče tudi stegno, glutealni predel ali deltoidni predel.
When two types of insulin are mixed, draw the amount of fast-acting insulin first, followed by the amount of long-acting insulin.
V primeru mešanja dveh vrst insulinov je najprej treba izvleči odmerek hitrodelujočega insulina in potem odmerek dolgodelujočega insulina.
Actrapid is accompanied by a package leaflet with detailed instruction for use to be followed.
Zdravilu Actrapid je priloženo navodilo za uporabo s podrobnimi navodili za pripravo, ki jih je treba upoštevati.